{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:03:18Z","timestamp":1785240198401,"version":"3.55.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/rheumatology\/ket466","type":"journal-article","created":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T01:24:18Z","timestamp":1390094658000},"page":"914-918","source":"Crossref","is-referenced-by-count":45,"title":["Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events"],"prefix":"10.1093","volume":"53","author":[{"given":"Koshiro","family":"Sonomoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Fukuyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,17]]},"reference":[{"key":"key\n\t\t\t\t20170522170138_ket466-B1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522170138_ket466-B2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522170138_ket466-B3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522170138_ket466-B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-9255-7-41","article-title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","volume":"7","author":"Meyer","year":"2010","journal-title":"J Inflamm"},{"key":"key\n\t\t\t\t20170522170138_ket466-B5","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/art.34329","article-title":"The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-gamma and interleukin-17 production by human CD4+ T cells","volume":"64","author":"Maeshima","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170138_ket466-B6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/ard.2011.150284","article-title":"The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon","volume":"71","author":"Rosengren","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522170138_ket466-B7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522170138_ket466-B8","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/j.1600-6143.2012.04127.x","article-title":"Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20170522170138_ket466-B9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1189\/jlb.0504282","article-title":"The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing","volume":"76","author":"Conklyn","year":"2004","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170522170138_ket466-B10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/01.tp.0000177643.05739.cd","article-title":"Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts","volume":"80","author":"Paniagua","year":"2005","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20170522170138_ket466-B11","first-page":"S153","article-title":"Tofacitinib (CP-690,550), an oral Janus kinase inhibitor: analysis of infections and all-cause mortality across phase 3 and long-term extension studies in patients with rheumatoid arthritis","volume":"63","author":"Cohen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522170138_ket466-B12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<973::AID-IMMU973>3.0.CO;2-P","article-title":"Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes","volume":"29","author":"Scotet","year":"1999","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20170522170138_ket466-B13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri2657","article-title":"Naive T cell homeostasis: from awareness of space to a sense of place","volume":"9","author":"Takada","year":"2009","journal-title":"Nat Rev Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/53\/5\/914\/17388663\/ket466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:31:22Z","timestamp":1503549082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/ket466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,17]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,1,17]]},"published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ket466","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,17]]}}}